Sirima, S. B., Richert, L., Chêne, A., Konate, A. T., Campion, C., Dechavanne, S., Semblat, J., Benhamouda, N., Bahuaud, M., Loulergue, P., Ouédraogo, A., Nébié, I., Kabore, M., Kargougou, D., Barry, A., Ouattara, S. M., Boilet, V., Allais, F., Roguet, G., Havelange, N., Lopez-Perez, E., Kuppers, A., Konaté, E., Roussillon, C., Kanté, M., Belarbi, L., Diarra, A., Henry, N., Soulama, I., Ouédraogo, A., Esperou, H., Leroy, O., Batteux, F., Tartour, E., Viebig, N. K., Thiebaut, R., Launay, O., & Gamain, B. (2020). pRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. Lancet infectious diseases, 20(5), 585–597. http://access.bl.uk/ark:/81055/vdc_100104367292.0x000015